The global poultry diagnostics market is estimated to be valued at USD 720.4 million in 2025 and is projected to reach USD 1,868.4 million by 2035, registering a CAGR of 10% over the forecast period.
| Metric | Value |
|---|---|
| Market Size (2025E) | USD 720.4 Million |
| Market Value (2035F) | USD 1,868.4 Million |
| CAGR (2025 to 2035) | 10% |
The poultry diagnostics market has been expanding steadily, supported by rising concerns over zoonotic disease transmission, production losses from endemic infections, and growing regulatory mandates for disease surveillance. Producers and veterinary laboratories have prioritized the adoption of rapid, reliable diagnostic tools to detect pathogens early and minimize outbreaks.
Advances in molecular testing technologies, including PCR and multiplex assays, have improved detection sensitivity and facilitated prompt intervention strategies. National and international guidelines have reinforced structured monitoring programs for diseases such as avian influenza and Newcastle disease, further stimulating demand for validated diagnostic solutions. Investments have been directed toward upgrading laboratory infrastructure, scaling testing capacity, and training personnel to standardize procedures.
ELISA Tests holds a revenue share of 53.2% has been attributed to ELISA tests, reflecting their widespread use as reliable, high-throughput tools for detecting antibodies in poultry populations. Utilization has been driven by the ability to process large sample volumes quickly, enabling comprehensive flock surveillance and timely intervention.
Laboratories and producers have prioritized ELISA assays due to their cost-efficiency, standardized protocols, and compatibility with multiple disease targets. Regulatory frameworks and certification programs have reinforced the role of ELISA in mandatory screening for economically significant diseases. Advances in assay sensitivity and automation have further supported adoption by reducing operator variability and improving result consistency.
Avian Influenza Leads the market with a revenue share of 47.8% which has been attributed to their critical role in mitigating the spread of highly pathogenic strains. Adoption has been reinforced by national surveillance initiatives and trade requirements that mandate rigorous testing to ensure product safety and market access. Veterinary authorities and integrated poultry producers have prioritized routine avian influenza screening to protect flock health and maintain continuity of operations.
Investments have been directed toward scaling diagnostic capacity and deploying rapid testing solutions capable of detecting evolving viral subtypes. Advances in molecular assays and high-sensitivity ELISA kits have improved detection reliability, strengthening disease management frameworks. These drivers have collectively established avian influenza as the dominant disease segment, with sustained demand expected as public health and export requirements intensify.
High Cost of Advanced Diagnostic Technologies
Small and mid-sized poultry farms face challenges in investing to cultivate molecular diagnostics and real-time disease monitoring tools. Furthermore, the unavailability of specialized diagnostic centres in developing areas is reducing the rapid identification of the disease, resulting in economic repercussions in the form of poultry deaths and unproductive egg and meat production.
To overcome these limitations, the different companies are aiming to develop cost-effective rapid test kits and mobile diagnostic solutions for poultry disease detection.
Growth of AI-Powered Disease Surveillance and Portable Diagnostic Devices
Artificial intelligence (AI), machine learning, and IoT-enabled disease monitoring systems are changing the paradigm of poultry diagnostics. By predicting disease outbreaks, analysing flock health data, and sending real-time alerts to farmers, AI-powered platforms enhance disease prevention efforts.
Also, the innovation of portable devices for diagnosis, biosensors, and smartphone approaches for testing are speeding the on-site diagnosis of poultry diseases to be more cost-effective and efficient. Businesses are likely to get a competitive edge in the evolving market by investing in automated real-time diagnostic solutions.
The poultry diagnostics market in the United States is driven by the rising incidences of avian diseases, including avian influenza and Newcastle disease. Increasing consumption of high-quality poultry products and strict government regulations regarding food safety and disease control are other factors contributing to market growth. Market growth is being propelled by the increasing adoption of advanced diagnostic techniques, such as PCR-based tests and ELISA kits.
| Country | CAGR (2025 to 2035) |
|---|---|
| United States | 9.8% |
The United Kingdom poultry diagnostics market is influenced by increasing focus on zoonotic diseases and stringent regulations on poultry health monitoring.
The market is gaining from a surge in the use of rapid testing methods as well as advances in veterinary diagnostics. Furthermore, the growing interest in antibiotic-free poultry has led farmers to adopt more precise disease identification strategies.
| Country | CAGR (2025 to 2035) |
|---|---|
| United Kingdom | 9.9% |
The poultry diagnostics market in the European Union is registering significant growth owing to rising consciousness about animal health and biosecurity measures.
The market is also being facilitated by government initiatives aimed at preventing the spread of avian diseases and lessen the utilization of antibiotics in the production of poultry. The growth is further attributed to better procurement and growing interest in molecular diagnostics and point-of-care testing solutions.
| Region | CAGR (2025 to 2035) |
|---|---|
| European Union (EU) | 10.0% |
The poultry diagnostics market is expected to thrive in Japan, owing to its emphasis on biosecurity and disease prevention in the poultry industry. Next generation sequencing and real-time PCR, which are advanced diagnostic technologies, are also gaining popularity in the country.
Rising focus of government agencies and private players on collaborations to invest in animal health research is further driving the growth of the animal health market.
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 10.1% |
The higher surge of avian influenza and other poultry diseases across South Korea is driving the demand for poultry diagnostic solutions in country. The key growth factors are the government´s focus on proactive disease surveillance and the increasing poultry farming in the country. Additionally, improvements in diagnostic tools are speeding up disease detection and increasing its accuracy.
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 10.0% |
The competitive landscape has been shaped by companies investing in multiplex assay development, rapid test kits, and automation-compatible platforms to strengthen market share. Leading manufacturers have prioritized regulatory approvals and global distribution partnerships to meet rising demand across large integrated producers and national laboratories.
Strategic collaborations with veterinary authorities and research institutions have been established to validate assay performance and expand disease detection panels. Training programs and technical support services have been implemented to improve user proficiency and standardize workflows. These initiatives are expected to drive product differentiation and reinforce leadership positions as disease surveillance and biosecurity requirements expand worldwide.
Key Development:
The overall market size for the Poultry Diagnostics Market was USD 720.40 Million in 2025.
The Poultry Diagnostics Market is expected to reach USD 1,868.4 Million in 2035.
The demand is driven by increasing poultry production, rising prevalence of avian diseases, growing awareness of food safety and biosecurity measures, advancements in rapid diagnostic testing, and stringent government regulations on poultry health monitoring.
The top 5 countries driving market growth are the USA, UK, Europe, Japan and South Korea.
The ELISA (Enzyme-Linked Immunosorbent Assay) segment is expected to command a significant share over the assessment period.
Explore Similar Insights
Poultry Diagnostics Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
